The oncogene BRAFV600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I− targeting to the membraneGarcilaso Riesco‐Eizaguirre, Pilar Santisteban|Endocrine Related Cancer|2006Cited by 367
ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activityJulia Ramírez-Moya, Pilar Santisteban|Oncogene|2020Cited by 130
An ADAR1-dependent RNA editing event in the cyclin-dependent kinase CDK13 promotes thyroid cancer hallmarksJulia Ramírez-Moya, Pilar Santisteban|Molecular Cancer|2021Cited by 63
ß-catenin signaling is required for RAS-driven thyroid cancer through PI3K activationAna Sastre-Perona, Pilar Santisteban|Oncotarget|2016Cited by 53
FOXE1 regulates migration and invasion in thyroid cancer cells and targets ZEB1Jesús Morillo-Bernal, Pilar Santisteban|Endocrine Related Cancer|2020Cited by 43